Cura is committed to advancing the development of cellular therapies that hold the potential to vanquish disease and reduce human suffering. Historically, blood transfusions and bone marrow transplants were the first FDA approved cellular therapies, and they are now the standard of care throughout much of the world. In the present day, a wide range of cells from the human body can be employed as therapies or treatments for dangerous diseases and debilitating medical conditions, such as cancer, autoimmune disease, rebuilding damaged cartilage in joints, spinal cord injuries, and helping patients with neurological disorders. Some of the cells that may be used include adult stem cells from many tissue types (e.g. heart, liver, lung), mesenchymal stem cells, dendritic cells, and pancreatic islet cells.